4th Fosamax ONJ lawsuit going to trial
Another lawsuit against Merck alleging that its Fosamax bisphosphonate drug causes osteonecrosis of the jaw (ONJ) will go to court beginning May 9, 2011, according to a story on aboutlawsuits.com. The plaintiff, Carolyn Hester, 75, of Florida claims she was prescribed Fosamax in 1999 and subsequently developed ONJ, leading to “severe and permanent injury” and “life-long complications.” U.S. District Judge John Keenan is presiding over pretrial litigation for the federal

